Jubilant Pharmova has appointed Arun Kumar Sharma as its Chief Financial Officer (CFO), effective October 1, 2025. This is an interim appointment to ensure a smooth transition while the company identifies and appoints a permanent CFO. Sharma previously held various positions within the Jubilant Bhartia Group, including CFO roles at Jubilant Pharma Holdings Inc. USA and Jubilant Lifesciences Limited.
Interim CFO Announcement
Jubilant Pharmova has announced the appointment of Arun Kumar Sharma as Chief Financial Officer (CFO) effective October 1, 2025. This appointment follows a board meeting held on September 23, 2025, where the decision was made based on recommendations from the Nomination, Remuneration and Compensation Committee, as well as the Audit Committee.
Details of the Appointment
The appointment of Mr. Sharma is for an interim period. The company is currently undergoing the process of identifying and appointing a permanent CFO and is intended to ensure a smooth leadership transition. Mr. Sharma has a long history with the Jubilant Bhartia Group, having previously served as CFO of Jubilant Pharma Holdings Inc. USA for approximately 4 years, and Jubilant Lifesciences Limited (Chemical Business) for approximately 3 years. He also served Jubilant Pharmova Limited for approximately 2 years (April 2021-May 2023).
Source: BSE
